Related Experiment Videos
Corticosteroid-induced dermal atrophy in the rat
The Journal of Investigative Dermatology
|November 1, 1977
Summary
Topical corticosteroids applied to rat skin cause dose-dependent dermal atrophy. This localized effect correlates with anti-inflammatory potency, independent of fluorine presence in the steroid molecule.
Area of Science:
- Dermatology
- Pharmacology
- Toxicology
Background:
- Corticosteroids are widely used for their anti-inflammatory properties.
- Topical corticosteroids can cause localized side effects, including skin thinning (dermal atrophy).
- Understanding the factors influencing corticosteroid-induced dermal atrophy is crucial for safe therapeutic use.
Purpose of the Study:
- To investigate and quantify corticosteroid-induced dermal atrophy in a rat model.
- To compare the atrophogenic potency of various topical corticosteroids.
- To determine the relationship between dermal atrophy and anti-inflammatory potency.
Main Methods:
- Daily topical application of ethanolic corticosteroid solutions to rat flank skin for 12 days.
- Measurement of skin plug weights from treated and control areas to assess dermal thinning.
- Dose-response assessment for multiple corticosteroids.
Main Results:
- All tested corticosteroids (hydrocortisone, hydrocortisone butyrate, dexamethasone, betamethasone, desonide, triamcinolone acetonide) induced dose-dependent dermal atrophy.
- The degree of skin thinning was directly proportional to the applied corticosteroid dose.
- Potency in the dermal atrophy assay correlated directly with topical anti-inflammatory potency in rats.
- Fluorine presence in the steroid molecule did not influence atrophy induction.
Conclusions:
- Topical corticosteroids induce localized dermal atrophy in rats.
- Dermal atrophy is a predictable side effect that correlates with anti-inflammatory efficacy.
- This model allows for the assessment of topical corticosteroid potency and potential side effects.